The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer

Journal of Nuclear Medicine

Volumn 51, Issue 9, 2010, Pages 1361-1367

  Grewal, Ravinder K ^a   Tuttle, R Michael ^a   Fox, Joseph ^a   Borkar, Sunita ^a   Chou, Joanne F ^a   Gonen, Mithat ^a   Strauss, H William ^a   Larson, Steven M ^a   Schöder, Heiko ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

131I; Posttherapy scan; Risk classification; SPECT CT; Thyroid cancer

Indexed keywords

IODINE 131; THYROGLOBULIN; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS; DRUG EFFECT; FEMALE; HUMAN; IODINE 131 UPTAKE TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT CARE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROIDECTOMY; TUMOR ABLATION; TUMOR CLASSIFICATION; ADOLESCENT; AGED; CELL DIFFERENTIATION; LYMPH NODE METASTASIS; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RECURRENT DISEASE; RISK ASSESSMENT; SCINTISCANNING; THYROID GLAND; THYROID TUMOR; TIME; TRANSPORT AT THE CELLULAR LEVEL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RECURRENCE; RISK ASSESSMENT; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77957061866     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.075960     Document Type: Article

References (16)

1. Tuttle RM, Leboeuf R, Shaha AR. Medical management of thyroid cancer: a risk adapted approach. J Surg Oncol. 2008;97:712-716. (Pubitemid 351812974)
2. 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2004;31:1435-1442.
3. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
4. Fleiss JL, Levin B, Paik MC. The analysis of data from matched samples. In: Fleiss JL, Levin B, Paik MC, eds. Statistical Methods for Rates and Proportions. Malden, MA: Wiley-Interscience; 2003:373-406.
5. 131I SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med. 2003;44:1905-1910.
6. 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma. J Nucl Med. 2008;49:1952-1957.
7. 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma. AJR. 2008;191:1785-1794.
8. 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. J Nucl Med. 2009;50:18-23.
9. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging. J Nucl Med. 2009;50:184-190.
10. 131I scintigraphy for thyroid cancer. J Clin Endocrinol Metab. 2009;94:2075-2084.
11. 131I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen. Eur J Nucl Med Mol Imaging. 2009;36:886-893.
12. Balachandran S, Sayle BA. Value of thyroid carcinoma imaging after therapeutic doses of radioiodine. Clin Nucl Med. 1981;6:162-167. (Pubitemid 11100981)
13. Nemec J, Rohling S, Zamrazil V, Pohunkova D. Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancers. J Nucl Med. 1979;20:92-97. (Pubitemid 9129558)
14. Tachi Y, Iwano S, Kato K, Tadokoro M, Naganawa S. Diagnostic whole-body scanning before radioiodine therapy for pulmonary metastases of differentiated thyroid cancer: predictive value and recommendations. Clin Nucl Med. 2008;33:845-851.
15. Ruf J, Lehmkuhl L, Bertram H, et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun. 2004;25:1177-1182. (Pubitemid 39614278)
16. Tuttle RM. Risk-adapted management of thyroid cancer. Endocr Pract. 2008;14:764-774.